Liquid Biopsy Market

Liquid Biopsy Market to Witness 26% CAGR Boom Through 2023-28 – Latest MarkNtel Advisors Report

MarkNtel Advisors, a leading market research firm, has showed its latest study titled “Liquid Biopsy Market“, offering a detailed industry overview and market perspective. This comprehensive research provides insights into the current state of the market, highlighting recent advancements and emerging trends.

The report combines in-depth quantitative analysis with qualitative analysis; it ranges from macro-overviews of the overall market size, industry chain, and market dynamics to micro details of segment markets. This, as a result, provides a thorough overview of the industry under study as well as a profound understanding of all of its important features.

Analysis and Insights into the Liquid Biopsy Market: 2023-2028

The Liquid Biopsy Market size is estimated to grow at a CAGR of around 26% during the forecast period, i.e., 2023-28.

“In case you missed it, we are currently revising our reports. Click on the below to get the latest research data with forecasts for years 2024 to 2030, including market size, industry trends, and competitive analysis. It wouldn’t take long for the team to deliver the most recent version of the report.”

Download the PDF Sample Copy (Including FULL TOC, Graphs, and Tables) of this Report – https://www.marknteladvisors.com/query/request-sample/global-liquid-biopsy-market.html                              

What are the primary factors driving the growth of the Liquid Biopsy Market?

Key Driver: Surge in Cancer Cases Across the Globe

The number of cancer cases has surged significantly on a global scale. Environmental factors are the leading causes of cancer. The rise in cancer diagnosis has led various countries and international health organizations to undertake various initiatives to spread awareness about cancer. With this increase, Liquid biopsy is preferred for its multiple advantages, counting low-cost, early prognosis, tumor heterogeneity identification, drug resistance, therapeutic drug monitoring, and the most ascendant, patient comfort by eliminating the need for surgery. Consecutively, this increase in preference for Liquid Biopsies is expected to increase the Market during the forecasting period.

Liquid Biopsy Market Segmentation:

The Liquid Biopsy Market is categorized in to different segments. Analyzing growth across these segments enables a comprehensive understanding of key growth areas within the industry. This segmentation provides valuable market insights, empowering stakeholders to make strategic decisions and identify primary market applications effectively.

By Work Process

-Sample Preparation              

-Library Preparation

-Sequencing

-Data Analysis        

By Technology

-PCR

–RT-PCR

–dPCR

–Multiplex PCR

–Others

-NGS

-FISH

-Other Technologies

By Usage

-RUO

-Clinical

By Sample Type

-Blood

-Urine

-Saliva

-Cerebrospinal Fluid

  • the Blood sample is estimated to dominate the market in the forecasting years.

By Products

-Test /Services

-Kits and Consumables

-Instruments

By Circulating Biomarkers

-Circulating Tumor Cells

-Cell-free DNA

-Circulating Cell-Free RNA  

-Exosomes and Extracellular Vesicles          

-Others                    

By Disease Type

-Lung Cancer

-Breast Cancer

-Prostate Cancer

-Colorectal Cancer

-Melanoma

-Other Cancers

-Non-Oncology Disorders

By Clinical Application

-Treatment Monitoring

-Prognosis and Recurrence Monitoring

-Treatment Selection

-Diagnosis and Screening

Geographical Analysis into the Liquid Biopsy Market:

  • North America: The US, Canada, Mexico
  • Europe: United Kingdom, Germany, France, Spain, Italy, and Others
  • Asia-Pacific: China, India, Japan, South Korea, South East Asia
  • South America: Brazil, and Others
  • Middle East & Africa: Saudi Arabia, UAE, South Africa

Read Detailed Index of full Research Study at – https://www.marknteladvisors.com/research-library/global-liquid-biopsy-market.html                                            

Competitive Landscape and Liquid Biopsy Market Share Analysis:

The competitive landscape of the Liquid Biopsy Market includes comprehensive details about competitors. These details encompass company overviews, financial performance, revenue generation, market potential, investments in research and development, new market strategies, production facilities, strengths and weaknesses, product launches, ongoing trials, approvals, patents, product range, dominant applications, and technology life cycle.

The report features major players including:

Bio-Rad Laboratories, Biocept Inc, Abcodia Ltd, Chronix Biomedical, Epic Sciences Inc, Hoffmann-La Roche AG, Cynvenio Biosystems, Inc., GUARDANT HEALTH, INC, Illumina, Inc., NeoGenomics Laboratories, Inc., Menarini Silicon Biosystems, Inc., Qiagen N.V., Thermo Fisher Scientific, Personal Genome Diagnostics, Inc., Qiagen N.V. etc.

Market research studies from MarkNtel Advisors are offered in PDF, Excel and PowerPoint formats. Within 24 hours of the payment being successfully received, the report will be sent to your email address.

Questions Addressed in this Study

  • What factors are driving the Liquid Biopsy Market growth?
  • How is the Liquid Biopsy Market expected to grow over the next five years?
  • What are the key insights into the current trends in the Liquid Biopsy Market?
  • What is the current size of the Liquid Biopsy Market, and how is it projected to change in the future?
  • What is the future outlook for the Liquid Biopsy Market in terms of technological advancements and market expansion?

Why choose MarkNtel?

MarkNtel Advisors is a leading market research company, consulting, & data analytics firm that provides an extensive range of strategic reports on diverse industry verticals. We deliver data to a substantial & varied client base, including multinational corporations, financial institutions, governments, & individuals, among others.

Our specialization in niche industries & emerging geographies allows our clients to formulate their strategies in a much more informed way and entail parameters like Go-to-Market (GTM), product development, feasibility analysis, project scoping, market segmentation, competitive benchmarking, market sizing & forecasting, & trend analysis, among others, for 14.8 diverse industrial verticals.

Contact Us –

Call: 📞 +1 628 895 8081 +91 120 4278433

Email: 📧 sales@marknteladvisors.com

Visit to know more: 🌐 https://www.marknteladvisors.com

Reply...